IDH1 and central nervous system cancer: The data strongly indicate that ALKBH2-mediated DNA repair is involved in the defense against ART-induced DNA damage and propose ART as a therapeutic supplemental agent notably for IDH1/2-mutated gliomas and presumably also other cancers displaying this mutation.